JP2019529479A5 - - Google Patents

Download PDF

Info

Publication number
JP2019529479A5
JP2019529479A5 JP2019516691A JP2019516691A JP2019529479A5 JP 2019529479 A5 JP2019529479 A5 JP 2019529479A5 JP 2019516691 A JP2019516691 A JP 2019516691A JP 2019516691 A JP2019516691 A JP 2019516691A JP 2019529479 A5 JP2019529479 A5 JP 2019529479A5
Authority
JP
Japan
Prior art keywords
patient
composition
composition according
reduction
lipase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019516691A
Other languages
English (en)
Japanese (ja)
Other versions
JP7329441B2 (ja
JP2019529479A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/053961 external-priority patent/WO2018064303A1/en
Publication of JP2019529479A publication Critical patent/JP2019529479A/ja
Publication of JP2019529479A5 publication Critical patent/JP2019529479A5/ja
Priority to JP2021134127A priority Critical patent/JP2021178874A/ja
Application granted granted Critical
Publication of JP7329441B2 publication Critical patent/JP7329441B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019516691A 2016-09-30 2017-09-28 患者におけるishak線維症ステージに基づいた肝線維症の軽減方法及びライソゾーム酸性リパーゼ欠損症の治療方法 Active JP7329441B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021134127A JP2021178874A (ja) 2016-09-30 2021-08-19 患者におけるishak線維症ステージに基づいた肝線維症の軽減方法及びライソゾーム酸性リパーゼ欠損症の治療方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201662402183P 2016-09-30 2016-09-30
US62/402,183 2016-09-30
US201662420233P 2016-11-10 2016-11-10
US62/420,233 2016-11-10
US201762456511P 2017-02-08 2017-02-08
US62/456,511 2017-02-08
PCT/US2017/053961 WO2018064303A1 (en) 2016-09-30 2017-09-28 Methods for reducing liver fibrosis and treating lysosomal acid lipase deficiency in patients based on ishak fibrosis stage

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021134127A Division JP2021178874A (ja) 2016-09-30 2021-08-19 患者におけるishak線維症ステージに基づいた肝線維症の軽減方法及びライソゾーム酸性リパーゼ欠損症の治療方法

Publications (3)

Publication Number Publication Date
JP2019529479A JP2019529479A (ja) 2019-10-17
JP2019529479A5 true JP2019529479A5 (enExample) 2020-11-05
JP7329441B2 JP7329441B2 (ja) 2023-08-18

Family

ID=60190917

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019516691A Active JP7329441B2 (ja) 2016-09-30 2017-09-28 患者におけるishak線維症ステージに基づいた肝線維症の軽減方法及びライソゾーム酸性リパーゼ欠損症の治療方法
JP2021134127A Withdrawn JP2021178874A (ja) 2016-09-30 2021-08-19 患者におけるishak線維症ステージに基づいた肝線維症の軽減方法及びライソゾーム酸性リパーゼ欠損症の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021134127A Withdrawn JP2021178874A (ja) 2016-09-30 2021-08-19 患者におけるishak線維症ステージに基づいた肝線維症の軽減方法及びライソゾーム酸性リパーゼ欠損症の治療方法

Country Status (5)

Country Link
US (1) US20200038491A1 (enExample)
EP (1) EP3518962B1 (enExample)
JP (2) JP7329441B2 (enExample)
ES (1) ES2888126T3 (enExample)
WO (1) WO2018064303A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7423815B2 (ja) * 2020-10-20 2024-01-29 セトラスホールディングス株式会社 治験管理装置、治験管理方法、治験管理プログラム及び治験管理システム
EP4259790A1 (en) * 2020-12-09 2023-10-18 Genethon Lysosomal acid lipase variants and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201909425T4 (tr) 2005-10-05 2019-07-22 Alexion Pharma Inc Yüksek ti̇treli̇ vi̇rüsün hizli üreti̇mi̇
MX338426B (es) 2010-04-23 2016-04-15 Synageva Biopharma Corp Enzima de enfermedad del almacenamiento lisosomico.

Similar Documents

Publication Publication Date Title
Diaz et al. Therapeutic strategies for severe acute lung injury
Futier et al. Lung-protective ventilation in abdominal surgery
Cavalli et al. Treating life-threatening myocarditis by blocking interleukin-1
Wang et al. Glycyrrhizin protects against porcine endotoxemia through modulation of systemic inflammatory response
Remy et al. Repurposing alpelisib, an anti‐cancer drug, for the treatment of severe TIE2‐mutated venous malformations: preliminary pharmacokinetics and pharmacodynamic data
Tabbutt et al. Severe influenza B myocarditis and myositis
WO2019024758A1 (zh) 一种糖苷类化合物在制备用于治疗肝纤维化药物中的应用
Miyamoto et al. Rupture of a coronary artery aneurysm in Kawasaki disease: a rare case and review of the literature for the past 15 years
Dubey et al. Anesthetic considerations in a patient with large anterior mediastinal mass
Xin et al. Effect of resection following downstaging of unresectable hepatocelluar carcinoma by transcatheter arterial chemoembolization
Takahashi et al. Living donor liver transplantation with noninvasive ventilation for exertional heat stroke and severe rhabdomyolysis
Avoine et al. Total liquid ventilation efficacy in an ovine model of severe meconium aspiration syndrome
Strecker et al. One hundred ten days of extracorporeal membrane oxygenation in a young woman with postpartum cerebral venous thrombosis and acute respiratory distress syndrome
Cena et al. New Impella cardiac power device used in patient with cardiogenic shock due to nonischemic cardiomyopathy
Loyson et al. Hemorrhage of liver and bone metastases as a result of rapid response to dual BRAF/MEK inhibition in metastatic melanoma: a case report
Tahara et al. Successful shunt closure and improvement of hemodynamics in an ASD patient with severe pulmonary arterial hypertension and small shunt following a long-term use of bosentan
Vlahovic et al. Diffuse neonatal hemangiomatosis treatment with cyclophosphamide: a case report
Miksad et al. Hepatic hydrothorax associated with vitamin A toxicity
Akbulut et al. BCG sepsis following inadvertent intravenous BCG administration for the treatment of bladder cancer can be effectively cured with anti-tuberculosis medications
Taupin et al. Lipiodol embolism following transarterial chemoembolization: an atypical case
Zhang et al. Effects of low doses of aerosolized iloprost combined with tadalafil in treatment of adult congenital heart disease with severe pulmonary arterial hypertension
Kun Effects of subdiaphragmatic cardiac compression on cardiac arrest during liver transplantation
JP2006028039A (ja) 肝線維症の予防方法
Verset et al. Fatal hemobilia in advanced hepatocellular carcinoma invading biliary tract after treatment with sorafenib and biliary stenting
Xiaoguang et al. Progress on liver diseases in 2021